Bank of New York Mellon Corp Sells 286,316 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank of New York Mellon Corp trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,102,587 shares of the medical equipment provider's stock after selling 286,316 shares during the period. Intuitive Surgical accounts for 0.5% of Bank of New York Mellon Corp's investment portfolio, making the stock its 27th biggest holding. Bank of New York Mellon Corp owned 1.43% of Intuitive Surgical worth $2,663,346,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,240 shares of company stock worth $3,529,040. Insiders own 0.80% of the company's stock.

Intuitive Surgical Trading Down 2.9 %

ISRG traded down $17.27 during midday trading on Tuesday, reaching $573.74. The company's stock had a trading volume of 2,548,276 shares, compared to its average volume of 1,739,679. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $204.35 billion, a P/E ratio of 89.51, a PEG ratio of 5.85 and a beta of 1.39. The company has a fifty day simple moving average of $566.43 and a 200 day simple moving average of $526.49.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.